ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa sesquihydrate -

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - methyldopa sesquihydrate 250mg;   - tablet - 250 mg - active: methyldopa sesquihydrate 250mg   excipient: carnauba wax citric acid monohydrate   colloidal silicon dioxide ethylcellulose guar gum hypromellose iron oxide red magnesium stearate powdered cellulose propylene glycol purified talc quinoline yellow sodium calcium edetate titanium dioxide

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa sesquihydrate, quantity: 283 mg (equivalent: methyldopa, qty 250 mg) - tablet, film coated - excipient ingredients: ethylcellulose; disodium edetate; magnesium stearate; guar gum; sodium starch glycollate; colloidal anhydrous silica; citric acid; titanium dioxide; hypromellose; sunset yellow fcf; quinoline yellow; macrogol 400 - indications as at 7 may 1996: hypertension (mild, moderate to severe)

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

teva pharmaceuticals usa inc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

cardinal health - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

bryant ranch prepack - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

avera mckennan hospital - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

rebel distributors corp - methyldopa (unii: 56lh93261y) (methyldopa - unii:56lh93261y) - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - methyldopa sesquihydrate 125mg (as the sesquihydrate. 142.86 including overage.) - film coated tablet - 125 mg - active: methyldopa sesquihydrate 125mg (as the sesquihydrate. 142.86 including overage.) excipient: carmellose magnesium stearate microcrystalline cellulose opaspray povidone starch

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - methyldopa sesquihydrate 500mg (as the sesquihydrate. 571mg including overage.) - film coated tablet - 500 mg - active: methyldopa sesquihydrate 500mg (as the sesquihydrate. 571mg including overage.) excipient: carmellose magnesium stearate microcrystalline cellulose opaspray povidone starch